ru24.pro
News in English
Октябрь
2024

Новости за 18.10.2024

Timothy Weah faces make-or-break game for Juve against Lazio

World Soccer Talk: World Cup 2014 

In the summer of 2023, Timothy Weah became the emblem of what was largely considered a disappointing and insufficient campaign for Juventus. After all, he was the club’s solitary addition to the first team, and he couldn’t quite fill in the large boots left by departing stalwart Juan Cuadrado. The 24-year-old had a mild start […]

In the summer of 2023, Timothy Weah became the emblem of what was largely considered a disappointing and insufficient campaign for Juventus. After all, he was the club’s solitary addition to the first team... Читать дальше...

Rate cut at this stage will be premature and very very risky, says RBI Governor

BigNewsNetwork.com 

New Delhi [India] October 18 (ANI): The Reserve Bank of India's (RBI) Governor Shaktikanta Das on Friday said that interest rate cut at this stage will be 'premature, and very, very risky'. Speaking at the fireside chat at the India Credit Forum event in Mumbai by Bloomberg, Governor Das warned against any premature interest rate cuts when inflation risk is still there. RBI still maintains a growth forecast of 7.2 per cen

African port growth hindered by poor road, rail networks, report says

Voice of America 

NAIROBI, KENYA — Africa has seen the capacity of its ports grow significantly over the years, but a report from the Africa Finance Corporation says the expansions, upgrades and investments have not led to better inland logistics and supply chains. Since 2005, African ports have received an estimated $15 billion in investments, allowing them to accommodate larger ships and offload more cargo for transportation across the continent. According to the African Development Bank, port development has led to increased traffic. Читать дальше...

Gland Pharma appoints Shyamakant Giri as new CEO

Economictimes.indiatimes.com 

Shyamakant Giri has been appointed as the new CEO of Gland Pharma, effective January 15, 2025. Giri brings over 25 years of experience in the pharmaceutical and healthcare sectors. The current CEO, Srinivas Sadu, will remain as the executive chairman to support the company's growth trajectory.